The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Purpose The purpose is a comparison of effectiveness of myo-inositol and metformin in infertile women with polycystic ovary syndrome (PCOS) treated with letrozole.Methods This study is a randomized single-blind controlled clinical trial undertaken in 150 infertile PCOS women. For all patients, letrozole is prescribed at a dose of 7.5 mg per day from the third day of menstruation for 5 days. Patients who did not ovulate were included and divided into three pretreatment groups: group I(control group), 200 µg of folic acid (as a placebo); group II, 1500 mg of metformin daily plus 200 µg of folic acid, and group III, inositol 2 g plus 200 µg of folic acid received twice daily for 3 months. In the last cycle, 7.5 mg letrozole was prescribed for the induction of ovulation. Primary outcomes were ovary function and pregnancy.Results The ovarian function was not significantly different in those groups, whereas the ovarian function of inositol + folic acid group in normal BMI found significantly higher than other BMI spectra. In addition, the ovarian function is significantly higher in the inositol + folic acid group by increasing the infertility duration. The incidence of pregnancy is lower in letrozole + folic acid + inositol group than the other groups; however, it is not significant.Conclusion The addition of inositol and metformin to the treatment of infertile PCOS women with letrozole resistance improves the ovarian function; however, it is not significant. Of note, inositol was more effective than metformin in patients with normal BMI.Irct registration number IRCT2017070234845N1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These studies used co-interventions of fertility treatment, either ovulation induction with letrozole (49), gonadotropin (50), or gonadotropin and intrauterine insemination (46) or in vitro fertilization (IVF) with or without intracytoplasmic sperm injection (ICSI) (25, 27, 40, 47, 48, 51, 55).”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [49]
In the citing paper
“Ten studies specifically enrolled women with PCOS who also had infertility (25, 27, 40, 46-51, 55, 56).”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [49]
In the citing paper
“Twelve used metformin at doses of 1000 mg to 2000 mg daily alone or in combination with FA as a comparator (26, 28, 30, 33, 39, 41, 42, 49-54, 56).”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [49]
In the citing paper
“There were 8 studies (25, 27, 31, 34, 46-49) that compared MI + FA to FA alone.”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [49]
In the citing paper
“The dose of MI used was 4 g daily in 6 of the studies (25, 31, 46-49) with 200 to 400 mcg of FA.”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [49]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
2 retracted
Badawy, A., Aal, I. A., & Abulatta, M. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.02.062 · Cited by 162
Retracted- Retracted
Nestler, J. E., Jakubowicz, D. J., Evans, W. S., & Pasquali, R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382603 · Cited by 784
Palomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426
Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice
Melo, A. S., Ferriani, R. A., & Navarro, P. A. (2015) · Clinics · doi:10.6061/clinics/2015(11)09 · Cited by 249
Genazzani, A. D., Lanzoni, C., Ricchieri, F., & Jasonni, V. M. (2008) · Gynecological Endocrinology · doi:10.1080/09513590801893232 · Cited by 221
Nardo, L. G., Yates, A. P., Roberts, S. A., Pemberton, P., & Laing, I. (2009) · Human Reproduction · doi:10.1093/humrep/dep225 · Cited by 188
Chiu, T. T. Y., Rogers, M. S., Law, E. L. K., Briton-Jones, C. M., Cheung, L. P., & Haines, C. J. (2002) · Human Reproduction · doi:10.1093/humrep/17.6.1591 · Cited by 182
The effects of old, new and emerging medicines on metabolic aberrations in PCOS
Bargiota, A., & Diamanti-Kandarakis, E. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812437355 · Cited by 119
Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial.
Ciotta, L., Stracquadanio, M., Pagano, I., Carbonaro, A., Palumbo, M. A., & Gulino, F. A. (2011) · PubMed · Cited by 112
Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
Raffone, E., Rizzo, P., & Benedetto, V. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903366996 · Cited by 100
Thomas, R. M., Nechamen, C. A., Mazurkiewicz, J. E., Ulloa-Aguirre, A., & Dias, J. A. (2011) · Endocrinology · doi:10.1210/en.2010-1353 · Cited by 89
Genazzani, A. D., Prati, A., Santagni, S., Ricchieri, F., Chierchia, E., Rattighieri, E., Campedelli, A., Simoncini, T., & Artini, P. G. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.685205 · Cited by 88
Colazingari, S., Treglia, M., Najjar, R., & Bevilacqua, A. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-2855-3 · Cited by 83
Goud, P. T. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.5.441 · Cited by 83
Ijuin, T., & Takenawa, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.335539 · Cited by 73
Zheng, X., Lin, D., Zhang, Y., Lin, Y., Song, J., Li, S., & Sun, Y. (2017) · Medicine · doi:10.1097/md.0000000000008842 · Cited by 62
Alpha-lactalbumin Effect on Myo-inositol Intestinal Absorption: In vivo and In vitro
Monastra, G., Sambuy, Y., Ferruzza, S., Ferrari, D., & Ranaldi, G. (2018) · Current Drug Delivery · doi:10.2174/1567201815666180509102641 · Cited by 47
Time of initiation of clomiphene citrate and pregnancy rate in polycystic ovarian syndrome
Dehbashi, S., Vafaei, H., Parsanezhad, M., & Alborzi, S. (2006) · International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · doi:10.1016/j.ijgo.2005.10.015 · Cited by 30
Letrozole Step-Up Protocol: a Successful Superovulation Protocol
Mitwally, M. F., Said, T., Galal, A., Chan, S., Cohen, M., Casper, R. F., & Magarelli, P. C. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.071 · Cited by 13
Kapral, M., Sośnicki, S., Wawszczyk, J., & Węglarz, L. (2014) · PubMed · Cited by 8
Hurley, E. G., Adams, S. R., Kalakota, N. R., Sroga, J. M., & Thomas, M. A. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.07.740 · Cited by 3
Cited by
Greff, D., Juhász, A. E., Váncsa, S., Váradi, A., Sipos, Z., Szinte, J., Park, S., Hegyi, P., Nyirády, P., Ács, N., et al. (2023) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-023-01055-z · Cited by 143
“Pourghasem, 2018 [44] Iran 2015–2016 50/50/50 30.”
MethodSaadati, S., Mason, T., Godini, R., Vanky, E., Teede, H. J., & Mousa, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16422 · Cited by 117
Fitz, V., Graca, S., Mahalingaiah, S., Liu, J., Lai, L., Butt, A., Armour, M., Rao, V., Naidoo, D., Maunder, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad762 · Cited by 70
“Three studies enrolled women with PCOS who were attempting to conceive and utilized co-interventions of letrozole (49), gonadotropin (50), or IVF (51).”
BackgroundMethodResultInfluentialMagzoub, R., Kheirelseid, E. A. H., Perks, C. M., & Lewis, S. J. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.01.025 · Cited by 49
Mohammadi, S., Eini, F., Bazarganipour, F., Taghavi, S. A., & Azizi, M. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00741-0 · Cited by 37
Self-citation
Metadata
- Authors
- Pourghasem, S., Bazarganipour, F., Taghavi, S. A., & Kutenaee, M. A.
- Affiliations
- Hormozgan University of Medical Sciences (IR)
- Yasuj University of Medical Sciences (IR)
- Venue
- Archives of Gynecology and Obstetrics
- Published
- 2019-02-05
- Volume
- 299
- Issue
- 4
- Pages
- 1193-1199
- ISSN
- 0003-9128 (ISSN-L)
- 0932-0067
- 1432-0711
- OpenAlex
- W2921299767
- Cited by
- 28
- References
- 22
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 3 · 2023: 6 · 2022: 3 · 2021: 4 · 2020: 1
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Gynecology and Obstetrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Keywords
- polycystic ovary syndrome, infertility, letrozole resistance, myo-inositol, metformin, folic acid, ovulation induction, ovarian function, pregnancy rate, body mass index, infertility duration
- MeSH terms
- Letrozole, Adult, Female, Folic Acid, Humans, Infertility, Female, Inositol, Metformin, Ovulation Induction, Polycystic Ovary Syndrome, Pregnancy, Single-Blind Method
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.